The Adaptor Molecule MyD88 Activates PI-3 Kinase Signaling in CD4+ T Cells and Enables CpG Oligodeoxynucleotide-Mediated Costimulation

Immunity

Volumn 25, Issue 5, 2006, Pages 783-793

  Gelman, Andrew E ^a   LaRosa, David F ^a   Zhang, Jidong ^a   Walsh, Patrick T ^a   Choi, Yongwon ^a   Sunyer, J  Oriol ^b   Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

MOLIMMUNO; SIGNALING

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GLYCOGEN SYNTHASE KINASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE MUTATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CPG ISLANDS; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION;

EID: 33846122035     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.08.023     Document Type: Article

References (42)

1. Akira S., Yamamoto M., and Takeda K. Role of adapters in Toll-like receptor signalling. Biochem. Soc. Trans. 31 (2003) 637-642
2. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
3. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., and Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275 (1997) 1930-1934
4. Bendigs S., Salzer U., Lipford G.B., Wagner H., and Heeg K. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur. J. Immunol. 29 (1999) 1209-1218
5. Burr J.S., Savage N.D., Messah G.E., Kimzey S.L., Shaw A.S., Arch R.H., and Green J.M. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J. Immunol. 166 (2001) 5331-5335
6. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197 (2003) 403-411
7. Caron G., Duluc D., Fremaux I., Jeannin P., David C., Gascan H., and Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 175 (2005) 1551-1557
8. Chen C., Edelstein L.C., and Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20 (2000) 2687-2695
9. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., and Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202 (2005) 321-331
10. Costello P.S., Gallagher M., and Cantrell D.A. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3 (2002) 1082-1089
11. Coudronniere N., Villalba M., Englund N., and Altman A. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc. Natl. Acad. Sci. USA 97 (2000) 3394-3399
12. Crellin N.K., Garcia R.V., Hadisfar O., Allan S.E., Steiner T.S., and Levings M.K. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 175 (2005) 8051-8059
13. Dragoi A.M., Fu X., Ivanov S., Zhang P., Sheng L., Wu D., Li G.C., and Chu W.M. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J. 24 (2005) 779-789
14. Dunne A., and O'Neill L.A. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett. 579 (2005) 3330-3335
15. Exley M., and Varticovski L. Evidence for phosphatidylinositol 3-kinase-dependent T cell antigen receptor (TCR) signal transduction. Mol. Immunol. 34 (1997) 221-226
16. Ferguson S.E., Han S., Kelsoe G., and Thompson C.B. CD28 is required for germinal center formation. J. Immunol. 156 (1996) 4576-4581
17. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., and Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3 (2002) 875-881
18. Gelman A.E., Zhang J., Choi Y., and Turka L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 172 (2004) 6065-6073
19. Holdorf A.D., Green J.M., Levin S.D., Denny M.F., Straus D.B., Link V., Changelian P.S., Allen P.M., and Shaw A.S. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190 (1999) 375-384
20. Kane L.P., Andres P.G., Howland K.C., Abbas A.K., and Weiss A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat. Immunol. 2 (2001) 37-44
21. Kitamura T. New experimental approaches in retrovirus-mediated expression screening. Int. J. Hematol. 67 (1998) 351-359
22. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., and Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9 (1995) 1965-1977
23. Mannon R.B., Nataraj C., and Pisetsky D.S. Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides. Cell. Immunol. 201 (2000) 14-21
24. Marengere L.E., Okkenhaug K., Clavreul A., Couez D., Gibson S., Mills G.B., Mak T.W., and Rottapel R. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28. J. Immunol. 159 (1997) 3220-3229
25. Martin M., Rehani K., Jope R.S., and Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6 (2005) 777-784
26. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
27. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7 (2000) 1063-1066
28. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 (2006) 3-9
29. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., and Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33 (2003) 597-605
30. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3 (2003) 317-330
31. Okkenhaug K., Wu L., Garza K.M., La Rose J., Khoo W., Odermatt B., Mak T.W., Ohashi P.S., and Rottapel R. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2 (2001) 325-332
32. Okkenhaug K., Bilancio A., Emery J.L., and Vanhaesebroeck B. Phosphoinositide 3-kinase in T cell activation and survival. Biochem. Soc. Trans. 32 (2004) 332-335
33. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560 (2005) 11-18
34. Peng G., Guo Z., Kiniwa Y., Voo K.S., Peng W., Fu T., Wang D.Y., Li Y., Wang H.Y., and Wang R.F. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309 (2005) 1380-1384
35. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., Lee J.Y., Kadesch T., Hardy R.R., Aster J.C., and Pear W.S. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11 (1999) 299-308
36. Reynolds L.F., Smyth L.A., Norton T., Freshney N., Downward J., Kioussis D., and Tybulewicz V.L. Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways. J. Exp. Med. 195 (2002) 1103-1114
37. Rhee S.H., Kim H., Moyer M.P., and Pothoulakis C. Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. J. Biol. Chem. 281 (2006) 18560-18568
38. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., Kawai K., Ohashi P.S., Thompson C.B., and Mak T.W. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261 (1993) 609-612
39. Ueda Y., Levine B.L., Huang M.L., Freeman G.J., Nadler L.M., June C.H., and Ward S.G. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7 (1995) 957-966
40. Wells A.D., Gudmundsdottir H., and Turka L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100 (1997) 3173-3183
41. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168 (2002) 554-561
42. Zheng Y., Vig M., Lyons J., Van Parijs L., and Beg A.A. Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J. Exp. Med. 197 (2003) 861-874